316 related articles for article (PubMed ID: 20367535)
21. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios.
Binard A; De Bandt M; Berthelot JM; Saraux A;
Arthritis Rheum; 2007 Apr; 57(3):481-6. PubMed ID: 17394219
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
Sulli A; Montecucco CM; Caporali R; Cavagna L; Montagna P; Capellino S; Fazzuoli L; Seriolo B; Alessandro C; Secchi ME; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():307-14. PubMed ID: 16855158
[TBL] [Abstract][Full Text] [Related]
23. [Polymyalgia rheumatica and giant cell arteritis: recent data and current situation].
Announ N; Guerne PA
Rev Med Suisse; 2008 Mar; 4(149):696-8, 701. PubMed ID: 18472729
[TBL] [Abstract][Full Text] [Related]
24. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
[TBL] [Abstract][Full Text] [Related]
25. Update on treatment of polymyalgia rheumatica.
Camellino D; Dejaco C
Reumatismo; 2018 Mar; 70(1):59-66. PubMed ID: 29589404
[TBL] [Abstract][Full Text] [Related]
26. Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled study.
Littman BH; Bjarnason D; Bryant G; Engelbrecht J; Cohen M; Mertz L; Weaver A; Hunder GG
J Rheumatol; 1995 Jun; 22(6):1097-103. PubMed ID: 7674236
[TBL] [Abstract][Full Text] [Related]
27. Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update.
González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
Expert Opin Pharmacother; 2018 Aug; 19(11):1235-1244. PubMed ID: 30040482
[TBL] [Abstract][Full Text] [Related]
28. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
Cleuziou C; Binard A; De Bandt M; Berthelot JM; Saraux A
J Rheumatol; 2012 Feb; 39(2):310-3. PubMed ID: 22174199
[TBL] [Abstract][Full Text] [Related]
29. [Rheumatic polymyalgia].
Calvo Romero JM; Ramos Salado JL; Pérez Miranda M
An Med Interna; 2000 Jan; 17(1):42-6. PubMed ID: 10730406
[TBL] [Abstract][Full Text] [Related]
30. Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment.
Schillaci G; Bartoloni E; Pucci G; Pirro M; Settimi L; Alunno A; Gerli R; Mannarino E
Ann Rheum Dis; 2012 Jul; 71(7):1151-6. PubMed ID: 22267333
[TBL] [Abstract][Full Text] [Related]
31. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
[TBL] [Abstract][Full Text] [Related]
32. Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.
Salvarani C; Cantini F; Niccoli L; Catanoso MG; Macchioni P; Pulsatelli L; Padula A; Olivieri I; Boiardi L
J Rheumatol; 2003 Apr; 30(4):760-3. PubMed ID: 12672196
[TBL] [Abstract][Full Text] [Related]
33. [Methotrexate therapy of polymyalgia rheumatica].
Wagener P
Z Rheumatol; 1995; 54(6):413-6. PubMed ID: 8578892
[TBL] [Abstract][Full Text] [Related]
34. Polymyalgia rheumatica and temporal arteritis: managing older patients.
Pereira M; Kaine JL
Geriatrics; 1986 Jun; 41(6):54-5, 59-60, 63 passim. PubMed ID: 3710167
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Devauchelle-Pensec V; Berthelot JM; Cornec D; Renaudineau Y; Marhadour T; Jousse-Joulin S; Querellou S; Garrigues F; De Bandt M; Gouillou M; Saraux A
Ann Rheum Dis; 2016 Aug; 75(8):1506-10. PubMed ID: 26929219
[TBL] [Abstract][Full Text] [Related]
36. TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report.
Migliore A; Massafra U; Carloni E; Padalino C; Martin Martin S; Lasaracina F; Dibiase N; Alimonti A; Granata M
Eur Rev Med Pharmacol Sci; 2005; 9(6):373-8. PubMed ID: 16479743
[TBL] [Abstract][Full Text] [Related]
37. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic response to prednisone in relation to age in polymyalgia rheumatica: a comparison study.
Charpentier A; Verhoeven F; Sondag M; Guillot X; Prati C; Wendling D
Clin Rheumatol; 2018 Mar; 37(3):819-823. PubMed ID: 29380162
[TBL] [Abstract][Full Text] [Related]
39. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
Gonzalez-Gay MA; Garcia-Porrua C; Miranda-Filloy JA; Martin J
Drugs Aging; 2006; 23(8):627-49. PubMed ID: 16964987
[TBL] [Abstract][Full Text] [Related]
40. Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms.
Pego-Reigosa JM; Rodriguez-Rodriguez M; Hurtado-Hernandez Z; Gromaz-Martin J; Taboas-Rodriguez D; Millan-Cachinero C; Hernandez-Rodriguez I; Gonzalez-Gay MA
Arthritis Rheum; 2005 Dec; 53(6):931-8. PubMed ID: 16342107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
